Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Trimethoprim Imp. I (EP): 3-(Phenylamino)-2-(3,4,5- trimethoxybenzyl)prop-2-enenitrile (E/Z-mixture)

Trimethoprim Imp. I (EP): 3-(Phenylamino)-2-(3,4,5- trimethoxybenzyl)prop-2-enenitrile (E/Z-mixture) is listed in the pharmaceutical impurity collection under CAS 30078-48-9. Its represented structure has formula C19H20N2O3 and a calculated molecular weight of 324.38 g/mol.

2D chemical structure

O N N H O O

Chemical identity

Catalog name
Trimethoprim Imp. I (EP): 3-(Phenylamino)-2-(3,4,5- trimethoxybenzyl)prop-2-enenitrile (E/Z-mixture)
Common name
Trimethoprim Imp. I (EP)
Chemical name
3-(Phenylamino)-2-(3,4,5- trimethoxybenzyl)prop-2-enenitrile (E/Z-mixture)
CAS
30078-48-9
SMILES
COc1cc(CC(C#N)=CNc2ccccc2)cc(OC)c1OC
InChI
InChI=1S/C19H20N2O3/c1-22-17-10-14(11-18(23-2)19(17)24-3)9-15(12-20)13-21-16-7-5-4-6-8-16/h4-8,10-11,13,21H,9H2,1-3H3
InChIKey
LMGNGGBSQVPQCO-UHFFFAOYSA-N
Associated API
Trimethoprim

Record ID: A4715899236b9

Computed properties

C19H20N2O3 Molecular formula
324.38 g/molMolecular weight
324.1474 DaMonoisotopic exact mass
63.51 ŲTopological polar surface area
3.7745 Calculated LogP (Wildman–Crippen)
93.5627 cm³/molMolar refractivity (Wildman–Crippen)
5 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 5 10 15 20 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight324.3851.42
Calculated LogP (Wildman–Crippen)3.774575.19
Topological polar surface area63.5144.06
Hydrogen-bond acceptors565.12
Hydrogen-bond donors138.08
Rotatable bonds (strict)776.94

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC19H20N2O3dimensionless
Molecular weight324.38g/mol
Monoisotopic exact mass324.1474Da
Topological polar surface area63.51Ų
Calculated LogP (Wildman–Crippen)3.7745dimensionless
Molar refractivity (Wildman–Crippen)93.5627cm³/mol
Hydrogen-bond acceptors5count
Hydrogen-bond donors1count
Rotatable bonds (strict)7count
Heavy atoms24count
Heteroatoms5count
Rings2count
Aromatic rings2count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.2105fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area141.6366Ų
Valence electrons124count
Radical electrons0count
Bertz complexity723.9475index
Balaban J2.2292index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Trimethoprim Imp. I (EP): 3-(Phenylamino)-2-(3,4,5- trimethoxybenzyl)prop-2-enenitrile (E/Z-mixture)

Qualification and safety assessment of Trimethoprim Imp. I (EP): 3-(Phenylamino)-2-(3,4,5- trimethoxybenzyl)prop-2-enenitrile (E/Z-mixture)

Explore toxicological qualification of Trimethoprim Imp. I (EP): 3-(Phenylamino)-2-(3,4,5- trimethoxybenzyl)prop-2-enenitrile (E/Z-mixture) and ICH M7 mutagenic impurity assessment of Trimethoprim Imp. I (EP): 3-(Phenylamino)-2-(3,4,5- trimethoxybenzyl)prop-2-enenitrile (E/Z-mixture) for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Trimethoprim Imp. I (EP): 3-(Phenylamino)-2-(3,4,5- trimethoxybenzyl)prop-2-enenitrile (E/Z-mixture) and acceptable intake and limit justification for Trimethoprim Imp. I (EP): 3-(Phenylamino)-2-(3,4,5- trimethoxybenzyl)prop-2-enenitrile (E/Z-mixture). The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Trimethoprim Imp. I (EP): 3-(Phenylamino)-2-(3,4,5- trimethoxybenzyl)prop-2-enenitrile (E/Z-mixture)

Explore Altox services and software through the Altox Pharma-Hub.